BioSpace News Archive

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced that Troy Player has been appointed as President, Early Stage Development and Testing.

Interim Phase II bullous pemphigoid (BP) data demonstrated a rapid and significant improvement in symptoms with a mean 63% decline inBullous Pemphigoid Disease Area Index (BPDAI) score and mean 68% decline in blister score by day 42 in patients with moderate BP.

Company Emphasizes Faster, More Advanced CTs, Making Imaging Easier for COVID-19 Patients.

MEI Pharma, Inc. announced that the U.S. Food and Drug Administration granted Fast Track designation to ME-401, MEI’s investigational selective oral inhibitor of phosphatidylinositol 3-kinase delta for the treatment of adult Patients with relapsed or refractory follicular lymphoma who have received at least two prior systemic therapies.

The novel single-use micro-endoscope with multiple working channels, eliminates the risk of transmitting infections between patients.

All 6 patients treated with mavrilimumab showed resolution of fever and did not progress to mechanical ventilation; follow-on controlled study in Italy planned

Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technologies like machine learning, Varian (NYSE: VAR), today announced the newest release of its treatment planning system, Eclipse™ v16

Multiple highly potent, neutralizing antibodies already identified from convalesced patients

VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with the National Research Council of Canada (NRC), Canada’s largest federal research and development organization, to develop a pan-coronavirus vaccine candidate, targeting COVID-19, severe acute respirat

As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances: they must continue to dispense vital medications to their patients, and fight the spread of COVID-19 -- while keeping both employees and patients as safe as possible.